This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Abu-Shakra, M. Articles by Ritchie, S. Search for Related Content PubMed PubMed Citation Articles by Abu-Shakra, M. Articles by Ritchie, S. Social Bookmarking                         What's this?

The significance of anticardiolipin antibodies in patients with lupus nephritis

The Lupus Clinic, The Wellesley Hospital, University of Toronto, The Department of Pathology, The Toronto Hospital, University of Toronto, Toronto, Ontario, Canada

MB Urowitz

The Lupus Clinic, The Wellesley Hospital, University of Toronto, The Department of Pathology, The Toronto Hospital, University of Toronto, Toronto, Ontario, Canada

DD Gladman

The Lupus Clinic, The Wellesley Hospital, University of Toronto, The Department of Pathology, The Toronto Hospital, University of Toronto, Toronto, Ontario, Canada

S. Ritchie

The Lupus Clinic, The Wellesley Hospital, University of Toronto, The Department of Pathology, The Toronto Hospital, University of Toronto, Toronto, Ontario, Canada

The objective of this study was to determine whether anticardiolipin antibodies (ACL) in SLE patients are associated with a specific pattern of lupus nephritis and/or with renal microvascular changes. Patients with SLE, followed prospectively between June 1991-May 1994 at The Wellesley Hospital Lupus Clinic, who underwent a renal biopsy were included. The ACL was measured by the ELISA according to international standardized method. Renal biopsy morphology was assessed using the WHO criteria for the classification of lupus nephritis. Renal vascular changes included glomerular hyaline thrombi, intimal fibro sis and intraluminal thrombi of renal arterioles. There were 23 SLE patients. The mean age at diagnosis of SLE was 28.2 years and the mean disease duration was 6.3 years. Of these 10 (43%) had high levels of ACL. No difference in the frequency of severe nephritis (Class III and IV) was identified amongst patients with and without ACL. Mesangial nephritis was more common in patients with ACL 40% vs 0, p = 0.02). Glomerular hyaline thrombi occurred in 3 (13%) patients. None of them had positive ACL. Renal vascular lesions included intimal proliferation in 4 (ACL + , 1) occluded lumens by thrombi in 2 (ACL + 1). Our data indicate that the development of glomerular and/or microvascular changes is not related to the presence of ACL.

Key Words: Anticardiolipin • Lupus • Nephritis

Lupus, Vol. 5, No. 1, 70-73 (1996)
DOI: 10.1177/096120339600500113


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M E Zabaleta-Lanz, L E Munoz, F J Tapanes, R E Vargas-Arenas, I Daboin, Y Barrios, J A Pinto, and N E Bianco Further description of early clinically silent lupus nephritis Lupus, December 1, 2006; 15(12): 845 - 851. [Abstract] [PDF]

				W. Egner The use of laboratory tests in the diagnosis of SLE J. Clin. Pathol., June 1, 2000; 53(6): 424 - 432. [Full Text] [PDF]